Hepion Pharmaceuticals, Inc.
HEPA
$0.04
-$0.02-27.83%
OTC PK
| 12/31/2025 | 09/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 15.50% | -42.59% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 15.50% | -60.69% | |||
| Operating Income | -15.50% | 60.69% | |||
| Income Before Tax | -39.03% | 54.68% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -39.03% | 54.68% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -39.03% | 54.68% | |||
| EBIT | -15.50% | 60.69% | |||
| EBITDA | -15.72% | 61.04% | |||
| EPS Basic | -38.33% | 55.76% | |||
| Normalized Basic EPS | -18.93% | 62.06% | |||
| EPS Diluted | -38.33% | 55.76% | |||
| Normalized Diluted EPS | -18.93% | 62.06% | |||
| Average Basic Shares Outstanding | 0.49% | 2.58% | |||
| Average Diluted Shares Outstanding | 0.49% | 2.58% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||